PMO-167 Presence of Viable HCV RNA in Monocytes at the End of Treatment Predicts Relapse in Genotype 3 HCV Infection

Gut - United Kingdom
doi 10.1136/gutjnl-2012-302514b.167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype

PLoS ONE
Multidisciplinary
2008English

Optimization of Direct Anti-Viral Agent Treatment Schedule: Focus on HCV Genotype 3

United European Gastroenterology Journal
OncologyGastroenterology
2017English

Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients

Journal of Clinical Microbiology
Microbiology
2009English

Threshold Value of the Anti-HCV Test in the Diagnosis of HCV Infection

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2019English

Inspection of HCV-RNA in Peripheral Blood Monocytes of Patients With Chronic Hepatitis, After Treatment by Interferon (IFN).

Acta Hepatologica Japonica
Hepatology
1995English

Mechanism of Persistence in HCV Infection

Uirusu. Journal of virology
Medicine
2004English

PMO-145 Ethnicity Has No Impact on SVR Rates in Patients With HCV Genotype 3 Treated With Pegylated Interferon and Ribavirin: Abstract PMO-145 Figure 1

Gut
Gastroenterology
2012English

Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology
MedicineHepatology
2018English

Study on the Presence of HCV RNA in PBMC Compared With Plasma of Patients With Hepatitis C After Treatment

Iranian Journal of Virology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy